🇺🇸 FDA
Pipeline program

ZS802

IIT2022031

Unknown gene_therapy active

Quick answer

ZS802 for Hemophilia A is a Unknown program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hemophilia A
Phase
Unknown
Modality
gene_therapy
Status
active

Clinical trials